Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
ChAdOx1 nCoV-19 Emergency use authorization Experimental Vaccine Jan/04/2022 16 1
Favipiravir Potential treatment - clinical evidence Used to treat other disease Antiviral Sep/24/2021 27 7
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Jul/12/2021 92 22
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021 38 47
Azithromycin Potential treatment - clinical evidence Used to treat other disease Antiviral Feb/26/2021 19 10
Amiodarone  Potential treatment - clinical evidence Used to treat other disease Antiviral Oct/28/2020 5 1
n-(1-Adamantyl)-n'-(4-guanidinobenzyl)urea Potential treatment - theoretical effect Experimental Antiviral Aug/11/2020 1 0
Ethyl 2-[(E)-[[1-[2-[(4-carbamimidoylanilino)methyl]-1-methylbenzimidazol-5-yl]cyclopropyl]-pyridin-2-ylmethylidene]amino]oxyacetate Potential treatment - theoretical effect Experimental Antiviral Aug/11/2020 1 0
Bis(5-amidino-2-benzimidazolyl)methane ketone Potential treatment - theoretical effect Experimental Antiviral Aug/11/2020 1 0
Metocurine Potential treatment - theoretical effect Experimental Antiviral Aug/11/2020 1 0